Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Halofuginone Hydrobromide

EU orphan designation number: EU/3/01/074   
Active ingredient: Halofuginone Hydrobromide
Indication: Treatment of systemic sclerosis
Sponsor: PPD Global Ltd
Granta Park, Great Abington, Cambridge, Cambridgeshire CB21 6GQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/12/2001 Orphan designation EMEA/OD/032/01 (2001)4112 of 11/12/2001